Naproxen Sodium impurity E is a structural analog of the parent drug, featuring a naphthalene core substituted with a methoxy group at the 6-position and a propanoic acid side chain. Its distinct configuration arises from a synthetic byproduct pathway involving ethylation rather than methylation during naphthalene ring functionalization. The compound retains the carboxylic acid moiety critical for pharmacological activity but exhibits altered hydrophobicity due to an extended aliphatic chain. This impurity serves as an HPLC reference standard for quantifying process-related deviations in Naproxen Sodium synthesis.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1457356 ↗ | 25 mg | USD 838.00 |
C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OC
InChI=1S/C15H16O3/c1-10(15(16)18-3)11-4-5-13-9-14(17-2)7-6-12(13)8-11/h4-10H,1-3H3/t10-/m0/s1
ZFYFBPCRUQZGJE-JTQLQIEISA-N